Evaluation of proinflammatory cytokine production induced by linear and branched polyethylenimine/plasmid DNA complexes in mice

Journal of Pharmacology and Experimental Therapeutics

Volumn 317, Issue 3, 2006, Pages 1382-1390

  Kawakami, Shigeru ^a   Ito, Yoshitaka ^a   Charoensit, Pensri ^a   Yamashita, Fumiyoshi ^a   Hashida, Mitsuru ^a  

^a KYOTO UNIVERSITY   (Japan)

Author keywords

[No Author keywords available]

Indexed keywords

ALANINE AMINOTRANSFERASE; AMMONIUM CHLORIDE; CHOLESTEROL; CYTOKINE; GAMMA INTERFERON; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; INTERLEUKIN 12; LIPOSOME; N [1 (2,3 DIOLEYLOXY)PROPYL] N,N,N TRIMETHYLAMMONIUM CHLORIDE; NITROGEN; PHOSPHATE; PLASMID DNA; POLYETHYLENEIMINE; TUMOR NECROSIS FACTOR ALPHA; UNCLASSIFIED DRUG;

ALANINE AMINOTRANSFERASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DNA STRUCTURE; DOSE RESPONSE; DRUG BLOOD LEVEL; DRUG DISTRIBUTION; DRUG EFFECT; DRUG EFFICACY; DRUG SCREENING; FEMALE; GENETIC TRANSFECTION; IN VIVO STUDY; LIVER TOXICITY; MOLECULAR WEIGHT; MOUSE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ALANINE TRANSAMINASE; ANIMALS; CYTOKINES; DNA; FEMALE; GENE EXPRESSION; LIPOSOMES; MICE; MICE, INBRED ICR; MOLECULAR STRUCTURE; MOLECULAR WEIGHT; NF-KAPPA B; PARTICLE SIZE; PLASMIDS; POLYETHYLENEIMINE; TISSUE DISTRIBUTION;

EID: 33646814034     PISSN: 00223565     EISSN: 15210103     Source Type: Journal    
DOI: 10.1124/jpet.105.100669     Document Type: Article

References (41)

1. Akinc A, Thomas M, Klibanov AM, and Langer R (2005) Exploring polyethylenimine-mediated DNA transfection and the proton sponge hypothesis. J Gene Med 7:657-663.
2. Barnes PJ and Karin M (1997) Nuclear factor-κB: a pivotal transcription factor in chronic inflammatory diseases. N Engl J Med 336:1066-1071.
3. Boletta A, Benigni A, Lutz J, Remuzzi G, Soria MR, and Monaco L (1997) Nonviral gene delivery to the rat kidney with polyethylenimine. Hum Gene Ther 8:1243-1251.
4. Boussif O, Lezoualc HF, Zanta AM, Mergny DM, Scherman D, Demeneix B, and Behr JP (1995) A versatile vector for gene and oligonucleotide transfer into cells in culture and in vivo: polyethylenimine. Proc Natl Acad Sci USA 92:7297-7301.
5. Bragonzi A, Dina G, Villa A, Calori G, Biffi A, Bordignon C, Assael BM, and Conese M (2000) Biodistribution and transgene expression with nonviral cationic vector/DNA complexes in the lungs. Gene Ther 7:1753-1760.
6. Chollet P, Favrot MC, Hurbin A, and Coll JL (2002) Side-effects of a systemic injection of linear polyethylenimine-DNA complexes. J Gene Med 4:84-91.
7. David PS, Shalin N, Shannon JB, David AH, and Katryn JS (2000) Phosphorothioate backbone modification modulates macrophage activation by CpG DNA. J Immunol 165:4165-4173.
8. Freimark BD, Blezinger HP, Florack VJ, Nordstrom JL, Long SD, Deshpande DS, Nochumson S, and Petrak KL (1998) Cationic lipids enhance cytokine and cell influx levels in the lung following administration of plasmid: cationic lipid complexes. J Immunol 160:4580-4586.
9. Fumoto S, Kawakami S, Shigeta K, Higuchi Y, Yamashita F, and Hashida M (2005) Interaction with blood components plays a crucial role in asialoglycoprotein receptor-mediated in vivo gene transfer by galactosylated lipoplex. J Pharmacol Exp Ther 315:484-493.
10. Goula D, Benoist C, Mantero S, Merlo G, Levi G, and Demeneix BA (1998) Polyethylenimine-based intravenous delivery of transgenes to mouse lung. Gene Ther 5:1291-1295.
11. Hofland HEJ, Nagy D, Liu JJ, Spratt K, Lee YL, Danos O, and Sullivan SM (1997) In vivo Gene transfer by intravenous administration of stable cationic lipid/DNA complex. Pharm Res (N Y) 14:742-749.
12. Kawakami S, Fumoto S, Nishikawa M, Yamashita F, and Hashida M (2000a) In vivo gene delivery to the liver using novel galactosylated cationic liposomes. Pharm Res (N Y) 17:306-313.
13. Kawakami S, Sato A, Nishikawa M, Yamashita F, and Hashida M (2000b) Mannose receptor-mediated gene transfer into macrophages using novel mannosylated cationic liposomes. Gene Ther 7:292-299.
14. Kircheis R, Wightman L, Schreiber A, Robitza B, Rossler V, Kursa M, and Wagner E (2001) Polyethylenimine/DNA complexes shielded by transferrin target gene expression to tumors after systemic application. Gene Ther 8:28-40.
15. Kichler A, Leborgne C, Coeytaux E, and Danos O (2001) Polyethylenimine-mediated gene delivery: a mechanistic study. J Gene Med 3:135-144.
16. Klinman DM (2004) Immunotherapeutic uses of CpG oligodeoxynucleotides. Nat Rev Immunol 4:1-10.
17. Knowles MR, Hohneker KW, Zhou Z, Olsen JC, Noah TL, Hu PC, Leigh MW, and Boucher RC (1995) A controlled study of adenoviral-vector-mediated gene transfer in the nasal epithelium of patients with cystic fibrosis. N Engl J Med 333:823-831.
18. Krieg AM, Yi AK, Matson S, Waldschmidt TJ, Bishop GA, Teasdale R, Koretzky GA, and Klinman DM (1995) CpG motif in bacterial DNA trigger direct B-cell activation. Nature (Lond) 374:546-549.
19. Lenardo MJ and Baltimore D (1989) NF-κB: a pleiotropic mediator of inducible and tissue-specific gene control. Cell 58:227-229.
20. Li S, Wu SP, Whitmore M, Loeffert EJ, Wang L, Watkins SC, Pitt BR, and Huang L (1999) Effect of immune response on gene transfers to the lung via systemic administration of cationic vectors. Am J Physiol 276:L796-L804.
21. Liu F, Qi H, Huang L, and Liu D (1997) Factors controlling the efficiency of cationic lipid-mediated transfection in vivo via intravenous administration. Gene Ther 6:517-523.
22. Loisel S, Le Gall C, Doucet L, Ferec C, and Floch V (2001) Contribution of plasmid DNA to hepatotoxicity after systemic administration of lipoplexes. Hum Gene Ther 12:685-696.
23. Moghimi SM, Symonds P, Murray JC, Hunter AC, Debska G, and Szewczyk A (2005) A two-stage poly(ethylenimine)-mediated cytotoxicity: implications for gene transfer/therapy. Mol Ther 11:990-995.
24. Morimoto K, Nishikawa M, Kawakami S, Nakano T, Hattori Y, Fumoto S, Yamashita F, and Hashida M (2003) Molecular weight-dependent gene transfection activity of unmodified and galactosylated polyethylenimine on hepatoma cells and mouse liver. Mol Ther 7:254-261.
25. Neu M, Fischer D, and Kissel T (2005) Recent advances in rational gene transfer vector design based on poly(ethylene imine) and its derivatives. J Gene Med 7:992-1009.
26. Ross G, Erickson R, Knorr D, Motulsky AG, Parkman R, Samulski J, Straus SE, and Smith BR (1996) Gene therapy in the United States: a five-year status report. Hum Gene Ther 7:1781-1790.
27. Sakurai F, Nishioka T, Saito H, Baba T, Okuda A, Matsumoto O, Taga T, Yamashita F, Takakura Y, and Hashida M (2001) Interaction between DNA-cationic liposome complexes and erythrocytes is an important factor in systemic gene transfer via the intravenous route in mice: the role of the neutral helper lipid. Gene Ther 8:677-686.
28. Sakurai F, Terada T, Yasuda K, Yamashita F, Takakura Y, and Hashida M (2002) The role of tissue macrophages in the induction of proinflammatory cytokine production following intravenous injection of lipoplexes. Gene Ther 9:1120-1126.
29. Song YK, Liu F, Chu SY, and Liu D (1997) Characterization of cationic liposomemediated gene transfer in vivo by intravenous administration. Hum Gene Ther 8:1585-1594.
30. Tan Y, Liu F, Li Z, Li S, and Huang L (2001) Sequential injection of cationic liposome and plasmid DNA effectively transfects the lung with minimal inflammatory toxicity. Mol Ther 3:673-682.
31. Tan Y, Zhang JS, and Huang L (2002) Codelivery of NF-κB decoy-related oligodeoxynucleotide improves LPD-mediated systemic gene transfer. Mol Ther 6:804-812.
32. Tousignant JD, Gates AL, Ingram LA, Johnson CL, Nietupski JB, Cheng SH, Eastman SJ, and Scheule RK (2000) Comprehensive analysis of the acute toxicities induced by systemic administration of cationic lipid: plasmid DNA complexes in mice. Hum Gene Ther 11:2493-2513.
33. Tranchant I, Thompson B, Nicolazzi C, Mignet N, and Scherman D (2004) Physicochemical optimisation of plasmid delivery by cationic lipids. J Gene Med 6:24-35.
34. Whitmore M, Li S, and Huang L (1999) LPD lipopolyplex initiates a potent cytokine response and inhibits tumor growth. Gene Ther 6:1867-1875.
35. Wightman L, Kircheis R, Rossler V, Carotta S, Ruzicka R, Kursa M, and Wagner E (2001) Different behavior of branched and linear polyethylenimine for gene delivery in vitro and in vivo. J Gene Med 3:362-372.
36. Yang JP and Huang L (1997) Overcoming the inhibitory effect of serum on lipofection by increasing the charge ratio of cationic liposome to DNA. Gene Ther 4:950-960.
37. Yang Y, Nunes FA, Berencsi K, Furth EE, Gonczol E, and Wilson JM (1994) Cellular immunity to viral antigens limits E1-deleted adenoviruses for gene therapy. Proc Natl Acad Sci USA 91:4407-4411.
38. Yew NS, Wang KX, Przybylska M, Bagley RG, Stedman M, Marshall J, Scheule RK, and Cheng SH (1999) Contribution of plasmid DNA to inflammation in the lung after administration of cationic lipid: pDNA complexes. Hum Gene Ther 10:223-234.
39. Yew NS, Zhao H, Wu IH, Song A, Tousignant JD, Przybylska M, and Cheng SH (2000) Reduced inflammatory response to plasmid DNA vectors by elimination and inhibition of immunostimulatory CpG motifs. Mol Ther 1:255-262.
40. Yi AK, Tuetken R, Redford T, Waldschmidt M, Kirsch J, and Krieg AM (1998) CpG motifs in bacterial DNA activate leukocytes through the pH-dependent generation of reactive oxygen species. J Immunol 160:4755-4761.
41. Zou SM, Erbacher P, Remy JS, and Behr JP (2000) Systemic linear polyethylenimine (L-PEI)-mediated gene delivery in the mouse. J Gene Med 2:128-134.